Skip to main
TGTX
TGTX logo

TG Therapeutics (TGTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy TG Therapeutics (TGTX) Stock

About TG Therapeutics (TGTX)

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Market cap$5.71B
Yesterday's volume182
Revenue (TTM)$386.39M
Avg. daily volume2.51M
EBITDA (TTM)$60.08M
Open$36.85
Price / earnings ratio147.50x
Yesterday's range$35.74 - $37.22
Debt / equity106.92x
52 week range$16.65 - $46.48
5 year debt / equity71.32x
Beta (LTM)0.97x
Interest coverage1.75x
Dividend & yield$0.00 (0.00%)
Current ratio4.02x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

TG Therapeutics Stock Rating

What analysts recommend for TGTX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 53%
Buy 33%
Hold 7%
Sell 7%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for TGTX stock is $5.72B

The current P/E ratio for TGTX stock is 147.5

The 52-week high for TGTX stock is $46.48. The current TGTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for TGTX stock is $16.65. The current TGTX stock price $undefined has increased 100.00% from its 52-week low

No, the TGTX stock does not pay dividends to its shareholders

The target price for TGTX stock is $28.40 based on the average of what a group of analyst think TGTX stock could be worth at a future date. This is not a prediction by Public.com

How to buy TGTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TGTX stock

    Navigate to the Explore page. Then, type TGTX into the search bar. When you see TGTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TGTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

TG Therapeutics Stock Earnings

The value each TGTX share was expected to gain vs. the value that each TGTX share actually gained.

TG Therapeutics (TGTX) reported Q1 2025 earnings per share (EPS) of $0.03, missing estimates of $0.17 by 82.35%. In the same quarter last year, TG Therapeutics's earnings per share (EPS) was -$0.07. TG Therapeutics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.30.

Buy TG Therapeutics (TGTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.